{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:16:57Z","timestamp":1789607817710,"version":"build-2803163510"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The aim of this study is to examine the safety and distribution of Ad-EGFP-MDR1, an adenovirus encoding human multidurg resistance gene (human MDR1), in the mice colon carcinoma model.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>After bone marrow cells (BMCs) were infected with Ad-EGFP-MDR1, they were administered by intra bone marrow-bone marrow transplantation (IBM-BMT). Total adenovirus antibody and serum adenovirus neutralizing factor (SNF) were determined. Biodistribution of Ad-EGFP-MDR1 was detected by in situ hybridization and immunohistochemistry. The peripheral hematocyte white blood cell (WBC), haemoglobin (Hb), red blood cell (RBC) and platelet (Plt) counts were analyzed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Neither total adenovirus antibody nor SNF increased weeks after BMT. In situ hybridization and immunohistochemistry demonstrated concordant expression of human MDR1 and P-gp which were found in lung, intestine, kidney and BMCs after BMT, but not detected in liver, spleen, brain and tumor. No significant abnormality of the recovery hematocyte was observed on Day 30 after treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The results indicate that IBM-BMT administration of a replication defective adenovirus is a feasible mode of delivery, allowing exogenous transference. The findings in this study are conducted for the future long-term studies of safety assessment of Ad-EGFP-MDR1.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1756-9966-29-1","type":"journal-article","created":{"date-parts":[[2010,1,5]],"date-time":"2010-01-05T07:14:33Z","timestamp":1262675673000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Evaluation of biodistribution and safety of adenovirus vector containing MDR1 in mice"],"prefix":"10.1186","volume":"29","author":[{"given":"ZhenZhen","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YuXi","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GaiHuan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XianQing","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,1,4]]},"reference":[{"issue":"15","key":"248_CR1","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1200\/JCO.2005.04.5005","volume":"24","author":"AI Neugut","year":"2006","unstructured":"Neugut AI, Matasar M, Wang X, McBride R, Jacobson JS, Tsai WY, Grann VR, Hershman DL: Duration of adjuvant chemotherapy for colon cancer and survival among the elderly. J Clin Oncol. 2006, 24 (15): 2368-2375. 10.1200\/JCO.2005.04.5005.","journal-title":"J Clin Oncol"},{"key":"248_CR2","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1159\/000079485","volume":"66","author":"R Gerardo","year":"2004","unstructured":"Gerardo R, Aniello T, Antonio R, Diodoro C, Carmine P, Giorgio R: A Phase Study of Irinotecan Alternated with a Weekly Schedule of Oxaliplat, High-Dose Leucovorin and 48 Hour Infusion 5-Fluorouracil in Patients with Advanced Colorectal Cancer. Oncology. 2004, 66: 371-378. 10.1159\/000079485.","journal-title":"Oncology"},{"key":"248_CR3","doi-asserted-by":"crossref","unstructured":"Prete SP, Turriziani M, Massara MC, De Rossi A, Correale P, De Vecchis L, Torino F, Bonmassar L, Aquino A: Combined effects of 5-fluorouracil, folinic acid and oxaliplatin on the expression of carcinoembryonic antigen in human colon cancer cells: pharmacological basis to develop an active antitumor immunochemotherapy. J Exp Clin Cancer Res. 2008, 5-12. 10.1186\/1756-9966-27-5. 27","DOI":"10.1186\/1756-9966-27-5"},{"issue":"24","key":"248_CR4","doi-asserted-by":"publisher","first-page":"3732","DOI":"10.1200\/JCO.2007.12.2234","volume":"25","author":"T Andr\u00e9","year":"2007","unstructured":"Andr\u00e9 T, Quinaux E, Louvet C, Colin P, Gamelin E, Bouche O, Achille E, Piedbois P, Tubiana-Mathieu N, Boutan-Laroze A, et al: Phase III study comparing a semimonthly with a monthly regimen of fluorouracil and leucovorin as adjuvant treatment for stage II and III colon cancer patients: final results of GERCOR C96.1. J Clin Oncol. 2007, 25 (24): 3732-3738. 10.1200\/JCO.2007.12.2234.","journal-title":"J Clin Oncol"},{"issue":"1","key":"248_CR5","doi-asserted-by":"publisher","first-page":"8","DOI":"10.2325\/jbcs.13.8","volume":"13","author":"S Takahashi","year":"2006","unstructured":"Takahashi S, Ito Y, Hatake K, Sugimoto Y: Gene Therapy for Breast Cancer-Review of Clinical Gene Therapy Trials for Breast Cancer and MDR1 Gene Therapy Trial in Cancer Institute Hospital. Breast Cancer. 2006, 13 (1): 8-15. 10.2325\/jbcs.13.8.","journal-title":"Breast Cancer"},{"key":"248_CR6","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1002\/ijc.10206","volume":"98","author":"C Alexander","year":"2002","unstructured":"Alexander C, Stefan P, Wolfram O, Axel RZ, Dieter KH, Klaus K, et al: Genetic Protection of Repopulating Hematopoietic Cells with an Improved MDR1-Retrovirus Allows Administration of Intensified Chemotherapy Following Stem Cell Transplantation in Mice. Int J Cancer. 2002, 98: 785-792. 10.1002\/ijc.10206.","journal-title":"Int J Cancer"},{"issue":"7","key":"248_CR7","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1080\/07357900600981299","volume":"24","author":"CB Guo","year":"2006","unstructured":"Guo CB, Jin XQ: Chemoprotection Effect of Multidrug Resistance 1(MDR1) Gene Transfer to Hematopoietic Progenitor Cells and Engrafted in Mice with Cancer Allows Intensified Chemotherapy. Cancer Invest. 2006, 24 (7): 659-668. 10.1080\/07357900600981299.","journal-title":"Cancer Invest"},{"issue":"1","key":"248_CR8","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s00280-005-0144-y","volume":"58","author":"CB Guo","year":"2006","unstructured":"Guo CB, Li YC, Jin XQ: Chemoprotection effect of retroviral vector encoding multidrug resistance 1 gene to allow intensified chemotherapy in vivo. Cancer Chemother Pharmacol. 2006, 58 (1): 40-49. 10.1007\/s00280-005-0144-y.","journal-title":"Cancer Chemother Pharmacol"},{"key":"248_CR9","doi-asserted-by":"publisher","first-page":"3292","DOI":"10.1182\/blood.V97.10.3292","volume":"97","author":"K Taketoshi","year":"2001","unstructured":"Taketoshi K, Muneo I, Hiroko H, Naoya I, Takashi E, Ryokei Og, et al: Intra-bone marrow injection of allogeneic bone marrow cells: a powerful new strategy for treatment of intractable autoimmune diseases in MRL\/lpr mice. Blood. 2001, 97: 3292-3299. 10.1182\/blood.V97.10.3292.","journal-title":"Blood"},{"key":"248_CR10","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1167\/iovs.05-1321","volume":"47","author":"MW Wilson","year":"2006","unstructured":"Wilson MW, Fraga CH, Fuller CE, Rodriguez-Galindo C, Mancini J, Hagedorn N, et al: Immunohistochemical Detection of Multidrug-Resistant Protein Expression in Retinoblastoma Treated by Primary Enucleation. Invest Ophthalmol Vis Sci. 2006, 47: 1269-1273. 10.1167\/iovs.05-1321.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"248_CR11","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/S0014-4835(03)00122-2","volume":"77","author":"SF Wen","year":"2003","unstructured":"Wen SF, Chen Z, Nery J, Faha B: Characterization of adenovirus p21 gene transfer, biodistribution, and immune response after local ocular deliveryin New Zealand white rabbits. Experimental Eye Research. 2003, 77: 355-365. 10.1016\/S0014-4835(03)00122-2.","journal-title":"Experimental Eye Research"},{"issue":"5","key":"248_CR12","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1111\/j.1600-0609.2007.00824.x","volume":"78","author":"H Zhang","year":"2007","unstructured":"Zhang H, Wen Z, Tan S, Li C, Lan S, Li J: Optimization of multidrug resistance 1 gene transfer confers chemoprotection to human hematopoietic cells engrafted in immunodeficient mice. Eur J Haematol. 2007, 78 (5): 432-439. 10.1111\/j.1600-0609.2007.00824.x.","journal-title":"Eur J Haematol"},{"issue":"3","key":"248_CR13","doi-asserted-by":"publisher","first-page":"263","DOI":"10.2174\/1566523043346174","volume":"4","author":"P Haviernik","year":"2004","unstructured":"Haviernik P, Bunting KD: Safety concerns related to hematopoietic stem cell gene transfer using retroviral vectors. Curr Gene Ther. 2004, 4 (3): 263-276.","journal-title":"Curr Gene Ther"},{"issue":"1","key":"248_CR14","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ctrv.2006.09.006","volume":"33","author":"CA Rabik","year":"2007","unstructured":"Rabik CA, Dolan ME: Molecular Mechanisms of Resistance and Toxicity Associated with Platinating Agents. Cancer Treat Rev. 2007, 33 (1): 9-23. 10.1016\/j.ctrv.2006.09.006.","journal-title":"Cancer Treat Rev."},{"issue":"5","key":"248_CR15","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.ymthe.2004.02.018","volume":"9","author":"DL Gu","year":"2004","unstructured":"Gu DL, Nguyen T, Gonzalez AM, Printz MA, Pierce GF, Sosnowski BA, et al: Adenovirus Encoding Human Platelet-Derived Growth Factor-B Delivered in Collagen Exhibits Safety, Biodistribution, and Immunogenicity Profiles Favorable for Clinical Use. Mol Ther. 2004, 9 (5): 699-711. 10.1016\/j.ymthe.2004.02.018.","journal-title":"Mol Ther"},{"issue":"6","key":"248_CR16","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1089\/hum.2005.16.664","volume":"16","author":"S Ni","year":"2005","unstructured":"Ni S, Bernt K, Gaggar A, Li ZY, Kiem HP, Lieber A: Evaluation of Biodistribution and Safety of Adenovirus Vectors Containing Group B Fibers after Intravenous Injection into Baboons. Hum Gene Ther. 2005, 16 (6): 664-677. 10.1089\/hum.2005.16.664.","journal-title":"Hum Gene Ther"},{"key":"248_CR17","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/sj.gt.3302436","volume":"12","author":"E Galanis","year":"2005","unstructured":"Galanis E, Okuno SH, Nascimento AG, Lewis BD, Lee RA, Oliveira AM, et al: Phase I-II trial of ONYX-015 in combination with MAP chemotherapy in patients with advanced sarcomas. Gene Therapy. 2005, 12: 437-445. 10.1038\/sj.gt.3302436.","journal-title":"Gene Therapy"},{"key":"248_CR18","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/sj.cgt.7700870","volume":"13","author":"IA Atencio","year":"2006","unstructured":"Atencio IA, Grace M, Bordens R, Fritz M, Horowitz JA, Hutchins B, et al: Biological activities of a recombinant adenovirus p53(SCH 58500) administered by hepatic arterial infusion in a Phase 1 colorectal cancer trial. Cancer Gene Therapy. 2006, 13: 169-181. 10.1038\/sj.cgt.7700870.","journal-title":"Cancer Gene Therapy"},{"issue":"6","key":"248_CR19","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1182\/blood-2002-12-3742","volume":"102","author":"PA Plett","year":"2003","unstructured":"Plett PA, Frankovitz SM, Orschell CM: Distribution of marrow repopulating cells between bone marrow and spleen early after transplantation. Blood. 2003, 102 (6): 2285-2291. 10.1182\/blood-2002-12-3742.","journal-title":"Blood"},{"issue":"10","key":"248_CR20","doi-asserted-by":"publisher","first-page":"3521","DOI":"10.1182\/blood-2002-04-1256","volume":"100","author":"JF Zhong","year":"2002","unstructured":"Zhong JF, Zhan Y, Anderson WF, Zhao Y: Murine hematopoietic stem cell distribution and proliferation in ablated and nonablated bone marrow transplantation. Blood. 2002, 100 (10): 3521-3526. 10.1182\/blood-2002-04-1256.","journal-title":"Blood"},{"key":"248_CR21","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/sj.gt.3302347","volume":"12","author":"AN Varnavski","year":"2005","unstructured":"Varnavski AN, Calcedo R, Bove M, Gao G, Wilson JM: Evaluation of toxicity from high-dose systemic administration of recombinant adenovirus vector in vector-naive and pre-immunized mice. Gene Therapy. 2005, 12: 427-436. 10.1038\/sj.gt.3302347.","journal-title":"Gene Therapy"},{"issue":"21","key":"248_CR22","doi-asserted-by":"publisher","first-page":"10634","DOI":"10.1128\/JVI.01359-06","volume":"80","author":"JW Schoggins","year":"2006","unstructured":"Schoggins JW, Falck-Pedersen E: Fiber and Penton Base Capsid Modifications Yield Diminished Adenovirus Type 5 Transduction and Proinflammatory Gene Expression with Retention of Antigen-Specific Humoral Immunity. J Virol. 2006, 80 (21): 10634-10644. 10.1128\/JVI.01359-06.","journal-title":"J Virol"},{"issue":"12","key":"248_CR23","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1089\/hum.2006.17.1262","volume":"17","author":"M Johnson","year":"2006","unstructured":"Johnson M, Huyn S, Burton J, Sato M, Wu L: Differential biodistribution of adenoviral vector in vivo as monitored by bioluminescence imaging and quantitative polymerase chain reaction. Hum Gene Ther. 2006, 17 (12): 1262-1269. 10.1089\/hum.2006.17.1262.","journal-title":"Hum Gene Ther"},{"key":"248_CR24","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1089\/hum.2006.17.705","volume":"17","author":"MS Plog","year":"2006","unstructured":"Plog MS, Guyre CA, Roberts BL, Goldberg M, St George JA, Perricone MA: Preclinical safety and biodistribution of Adenovirus-Based Cancer Vaccines After Intradermal Delivry. Hum Gene Ther. 2006, 17: 705-716. 10.1089\/hum.2006.17.705.","journal-title":"Hum Gene Ther"},{"issue":"3","key":"248_CR25","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.jconrel.2006.11.030","volume":"117","author":"H Sakurai","year":"2007","unstructured":"Sakurai H, Sakurai F, Kawabata K, Sasaki T, Koizumi N, Huang H, et al: Comparison of gene expression efficiency and innate immune response induced by Ad vector and lipoplex. J Control Release. 2007, 117 (3): 430-437. 10.1016\/j.jconrel.2006.11.030.","journal-title":"J Control Release"},{"issue":"2","key":"248_CR26","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1080\/15569520701212167","volume":"26","author":"RW Veneziale","year":"2007","unstructured":"Veneziale RW, Bral CM, Sinha DP, Watkins RW, Cartwright ME, Rosenblum IY, et al: SCH 412499: biodistribution and safety of an adenovirus containing P21(WAF-1\/CIP-1) following subconjunctival injection in Cynomolgus monkeys. Cutan Ocul Toxicol. 2007, 26 (2): 83-105. 10.1080\/15569520701212167.","journal-title":"Cutan Ocul Toxicol"},{"key":"248_CR27","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1634\/stemcells.22-2-125","volume":"22","author":"K Nakamura","year":"2004","unstructured":"Nakamura K, Inaba M, Sugiura K, Yoshimura T, Kwon AH, Kamiyama Y, et al: Enhancement of allogeneic hematopoietic stem cell engraftment and prevention of GVHD by intrabone marrow bone marrow transplantation plus donor lymphocyte infusion. Stem Cells. 2004, 22: 125-134. 10.1634\/stemcells.22-2-125.","journal-title":"Stem Cells"},{"key":"248_CR28","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1111\/j.1349-7006.2007.00571.x","volume":"98","author":"S Takahashi","year":"2007","unstructured":"Takahashi S, Aiba K, Ito Y, Hatake K, Nakane M, Kobayashi T, et al: Pilot study of MDR1 gene transfer into hematopoietic stem cells and chemoprotection in metastatic breast cancer patients. Cancer Sci. 2007, 98: 1609-1616. 10.1111\/j.1349-7006.2007.00571.x.","journal-title":"Cancer Sci"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-9966-29-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T04:40:53Z","timestamp":1630471253000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/1756-9966-29-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1,4]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["248"],"URL":"https:\/\/doi.org\/10.1186\/1756-9966-29-1","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1,4]]},"assertion":[{"value":"29 August 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2010","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2010","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"1"}}